<div id="readability-page-1"><p>Milestone Asset Management LLC cut its position in  Axon Enterprise, Inc (NASDAQ:AXON - Free Report) by 94.1% in the 3rd quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 281 shares of the biotechnology company's stock after selling 4,493 shares during the quarter. Milestone Asset Management LLC's holdings in Axon Enterprise were worth $202,000 as of its most recent filing with the Securities and Exchange Commission.</p><div><p><span></span><span>Get <strong>Axon Enterprise</strong> alerts:</span></p></div><ul><li>Why Axon's 16% Surge Signals a New Era in Public Safety Tech</li></ul><p>A number of other large investors have also added to or reduced their stakes in AXON. Vanguard Group Inc. boosted its position in  Axon Enterprise by 3.5% in the 2nd quarter. Vanguard Group Inc. now owns 8,937,260 shares of the biotechnology company's stock valued at $7,399,515,000 after buying an additional 305,252 shares during the last quarter.  Geode Capital Management LLC increased its position in shares of  Axon Enterprise by 5.9% during the second quarter. Geode Capital Management LLC now owns 2,072,186 shares of the biotechnology company's stock worth $1,713,332,000 after acquiring an additional 115,349 shares during the last quarter.  Alliancebernstein L.P. lifted its stake in shares of  Axon Enterprise by 15.9% in the first quarter. Alliancebernstein L.P. now owns 1,284,935 shares of the biotechnology company's stock worth $675,812,000 after acquiring an additional 175,890 shares in the last quarter.  Vestor Capital LLC boosted its holdings in  Axon Enterprise by 438,636.3% in the second quarter. Vestor Capital LLC now owns 833,599 shares of the biotechnology company's stock valued at $690,170,000 after purchasing an additional 833,409 shares during the last quarter.  Finally, Norges Bank acquired a new stake in  Axon Enterprise during the 2nd quarter valued at approximately $637,806,000. 79.08% of the stock is owned by institutional investors and hedge funds. </p><h2>Analyst Upgrades and Downgrades</h2><p>AXON has been the topic of a number of recent analyst reports. JMP Securities  reaffirmed a &#34;market outperform&#34; rating and issued a $825.00 target price on shares of Axon Enterprise in a research report on Monday, September 29th. Cowen  reiterated a &#34;buy&#34; rating on shares of Axon Enterprise in a research note on Wednesday, November 5th. Weiss Ratings  restated a &#34;hold (c-)&#34; rating on shares of Axon Enterprise in a research note on Monday. UBS Group decreased their price target on Axon Enterprise from $840.00 to $610.00 and set a &#34;neutral&#34; rating for the company in a research note on Wednesday, November 5th. Finally, Morgan Stanley reduced their target price on Axon Enterprise from $760.00 to $713.00 and set an &#34;overweight&#34; rating on the stock in a report on Wednesday, December 17th. Fourteen equities research analysts have rated the stock with a Buy rating and four have assigned  a Hold rating to the stock. Based on data from MarketBeat.com, the stock currently has a consensus rating of &#34;Moderate Buy&#34; and a consensus target price of $802.71.</p><ul><li>MarketBeat Week in Review – 06/02 - 06/06</li></ul><p><b>Get Our Latest Stock Report on AXON</b></p><h2>Insider Activity</h2><p>In related news, Director Jeri Williams sold 100 shares of the business's stock in a transaction that occurred on Thursday, December 4th. The shares were sold at an average price of $550.63, for a total transaction of $55,063.00. Following the transaction, the director directly owned 1,316 shares of the company's stock, valued at approximately $724,629.08. The trade was a 7.06% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is accessible through the SEC website. Also, CAO Jennifer H. Mak sold 1,134 shares of the stock in a transaction that occurred on Friday, December 19th. The stock was sold at an average price of $600.00, for a total transaction of $680,400.00. Following the completion of the sale, the chief accounting officer owned 13,740 shares of the company's stock, valued at approximately $8,244,000. The trade was a 7.62% decrease in their position. The SEC filing for this sale provides additional information. In the last three months, insiders sold 65,540 shares of company stock worth $39,201,438. Corporate insiders own  4.40% of the company's stock. </p><h2>Axon Enterprise Stock Performance</h2><ul><li>AXON: Competition Intensifies as Motorola Makes $4.4B Acquisition</li></ul><p>Axon Enterprise stock opened at $591.15 on Friday. Axon Enterprise, Inc has a fifty-two week low of $469.24 and a fifty-two week high of $885.91. The firm's 50 day simple moving average is $601.45 and its 200-day simple moving average is $702.84. The company has a debt-to-equity ratio of 0.57, a current ratio of 3.12 and a quick ratio of 2.89. The company has a market cap of $46.65 billion, a P/E ratio of 187.07, a price-to-earnings-growth ratio of 135.77 and a beta of 1.40. </p><p>Axon Enterprise (NASDAQ:AXON - Get Free Report) last posted its quarterly earnings data on Wednesday, November 5th. The biotechnology company reported $1.17 EPS for the quarter, missing analysts' consensus estimates of $1.63 by ($0.46). The firm had revenue of $710.64 million during the quarter, compared to analyst estimates of $704.83 million. Axon Enterprise had a return on equity of 4.29% and a net margin of 10.05%.The company's revenue for the quarter was up 30.6% on a year-over-year basis. During the same period in the prior year, the business posted $1.45 EPS.  As a group, equities research analysts predict that  Axon Enterprise, Inc will post 5.8 EPS for the current year. </p><h2>About Axon Enterprise</h2> (Free Report)<p>Axon Enterprise, Inc develops technology and weapons systems for public safety and law enforcement agencies, combining hardware, software and cloud services. The company's hardware portfolio includes conducted energy weapons (commonly known as TASER devices), body-worn cameras and in-car camera systems. Axon pairs these devices with a suite of connected products and accessories designed to capture, store and manage field evidence.  </p><p>Beyond hardware, Axon operates a subscription-based software platform for digital evidence management, evidence review and records management.</p><h2>Featured Articles</h2><ul><li>Five stocks we like better than Axon Enterprise</li><li>Turn your &#34;dead money&#34; into $306+ monthly (starting this month)</li><li>Buffett, Gates and Bezos Quietly Dumping Stocks—Here's Why</li><li>Washington prepares for war</li><li>Put $1,000 into this stock by Jan 1 [Not NVDA]</li><li>The McDonald's Secret</li></ul><p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5BU0RBUSZTeW1ib2w9QVhPTg?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" width="650" height="350" original-src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5BU0RBUSZTeW1ib2w9QVhPTg"/></p><p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.</em></p><h2>Should You Invest $1,000 in Axon Enterprise Right Now?</h2><p>Before you consider Axon Enterprise, you'll want to hear this.</p><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Axon Enterprise wasn't on the list.</p><p>While Axon Enterprise currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.</p><p>View The Five Stocks Here</p>                  </div>

AXON

<p>Milestone Asset Management LLC reduced its holdings in Axon Enterprise, Inc by 94.1% in the 3rd quarter, owning 281 shares worth $202,000. Other investors like Vanguard Group Inc., Geode Capital Management LLC, and Alliancebernstein L.P. have adjusted their positions in Axon. Analysts have mixed ratings, with a consensus target price of $802.71. Insiders sold 65,540 shares worth $39,201,438 in the last three months. Axon Enterprise's stock performance shows a market cap of $46.65 billion.</p>

Milestone Asset Management LLC Reduces Holdings in Axon Enterprise, Inc $AXON